Flattened cone 2,8,14,20-tetrakis(L-valinamido)-[4]resorcinarene: An enantioselective allosteric receptor in the gas phase

Angewandte Chemie - International Edition

Volumn 45, Issue 17, 2006, Pages 2717-2720

  Botta, Bruno ^a   Caporuscio, Fabiana ^b   Subissati, Deborah ^b   Tafi, Andrea ^a   Botta, Maurizio ^b   Filippi, Antonello ^b   Speranza, Maurizio ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Allosteric effect; Enantioselectivity; Enzyme models; Gas phase kinetics; Host guest systems

Indexed keywords

ALLOSTERIC EFFECTS; ENANTIOSELECTIVITY; ENZYME MODELS; GAS PHASE KINETICS; HOST GUEST SYSTEMS;

BUTANE; CATALYST SELECTIVITY; CONFORMATIONS; DERIVATIVES; HYDROPHILICITY; HYDROPHOBICITY;

OLEFINS;

2,8,14,20 TETRAKIS(L VALINAMIDO)(4)RESORCINARENE; 2,8,14,20-TETRAKIS(L-VALINAMIDO)(4)RESORCINARENE; CALIXARENE; DRUG DERIVATIVE; PHENYLALANINE; RESORCINARENE; VALINE;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; GAS; KINETICS; STEREOISOMERISM;

ALLOSTERIC SITE; CALIXARENES; GASES; KINETICS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHENYLALANINE; STEREOISOMERISM; VALINE;

EID: 33746191851     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200503987     Document Type: Article

References (22)

1. A. Guidotti, J. Auta, J. M. Davis, E. Dong, D. R. Grayson, M. Veldic, X. Zhang, E. Costa, Psychopharmacology 2005, 180, 191.
2. J. A. Schetz, Mini-Rev. Med. Chem. 2005, 5, 555.
3. Z. G. Gao, S. K. Kim, A. P. Ijzerman, K. A. Jacobson, Mini-Rev. Med. Chem. 2005, 5, 545.
4. C. Geserick, H. A. Meyer, B. Haendler, Mol. Cell. Endocrinol. 2005, 236, 1.
5. B. M. Matata, M. M. Elahi, Recent Res. Dev. Biophys. 2004, 3, 93.
6. R. G. Pertwee, Life Sci. 2005, 76, 1307.
7. J. N. C. Kew, Pharmacol. Ther. 2004, 104, 233.
8. J. P. Pin, J. Kniazeff, V. Binet, J. Liu, D. Maurel, T. Galvez, B. Duthey, M. Havlickova, J. Blahos, L. Prezeau, P. Rondard, Biochem. Pharmacol. 2004, 68, 1565.
9. L. T. May, V. A. Avlani, P. M. Sexton, A. Christopoulos, Curr. Pharm. Des. 2004, 10, 2003.
10. L. P. Henderson, J. C. Jorge, Adv. Mol. Cell Biol. 2004, 32, 219.
11. D. S. Woodruff-Pak, Drug Dev. Res. 2002, 56, 335.
12. M. Emre, Int. J. Clin. Pract. Suppl. 2002, 127, 64.
13. For recent reviews on gas-phase enantioselectivity, see: a) M. Speranza, Adv. Phys. Org. Chem. 2004, 39, 147;
14. b) M. Speranza, Int. J. Mass Spectrom. 2004, 232, 277.
15. B. Botta, M. Botta, A. Filippi, A. Tafi, G. Delle Monache, M. Speranza, J. Am. Chem. Soc. 2002, 124, 7658.
16. B. Botta, A. Tafi, M. Botta, G. Delle Monache, A. Filippi, M. Speranza, Chem. Eur. J. 2004, 10, 4126.
17. B. Botta, D. Subissati, A. Tafi, G. Delle Monache, A. Filippi, M. Speranza, Angew. Chem. 2004, 116, 4871;
18. Angew. Chem. Int. Ed. 2004, 43, 4767.
19. T. Su, J. Chem. Phys. 1988, 88, 4102, 5355.
20. H. J. Schneider, A. K. Yatsimirsky, Principles and Methods in Supramolecular Chemistry, Wiley, New York, 2000.
21. B. Botta, G. Delle Monache, P. Salvatore, F. Gasparrini, C. Villani, M. Botta, F. Corelli, A. Tafi, E. Gacs-Baitz, A. Santini, C. Carvalho, D. Misiti, J. Org. Chem. 1997, 62, 932.
22. F. Mohamadi, N. G. J. Richards, W. C. Guida, R. Liskamp, M. Lipton, C. Caufield, G. Chang, T. Hendrickson, W. C. Still, J. Comput. Chem. 1990, 11, 440.